The first pediatric subjects of Moderna’s Phase 2/3 study have been vaccinated, according to the company in a recent press release. The study, which is also called the KidCOVE study, features the effectiveness of the company’s vaccine against COVID-19 in children ages six months to 11 years old. There will be approximately 6,750 participants from […]
Stéphane Bancel
March 22, 2021 |
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia